Biotech

All Articles

Navigator raises $100M to develop brand new autoimmune pipeline

.Navigator Medicines has outfitted on its own along with $100 million in collection A funds as the y...

Duality seeks cash money for ADC tests as IPO wave spreads to Asia

.China's Duality Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, looking for an u...

YolTech offers China civil liberties to genetics editing and enhancing therapy for $29M

.4 months after Mandarin gene editing and enhancing company YolTech Therapeutics took its cholestero...

Addex inventory rises after Indivior provides to $300M for substance

.Indivior is picking up a little particle allosteric modulator designed to alleviate substance use d...

Molecular Partners tweaks AML trial over 'suboptimal visibility'

.Molecular Partners has determined "suboptimal visibility" to its own tetra-specific T-cell engager ...

Despite mixed market, a financial backing resurgence might be being available in Europe: PitchBook

.While the biotech assets scene in Europe has reduced somewhat complying with a COVID-19 financing b...

8 months after a $213M fundraise, genetics editor Volume makes reduces

.After bring up $213 million in 2023-- one of the year's largest private biotech shots-- Tome Biosci...

BioMarin develops exec crew along with biotech vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, shootin...

Biopharma Q2 VC reached highest degree due to the fact that '22, while M&ampA slowed

.Equity capital backing right into biopharma rose to $9.2 billion throughout 215 handle the 2nd four...

Bicara, Zenas find IPOs to press late-phase assets toward market

.Bicara Therapies and also Zenas Biopharma have offered fresh incentive to the IPO market along with...